| Literature DB >> 34889229 |
Ming Wang1, Yang Cai, Yugang Jiang, Yong Peng.
Abstract
ABSTRACT: We aimed to identify the risk factors associated with intra- and postoperative cerebrospinal fluid (CSF) leakage in pituitary adenomas treated with endoscopic transsphenoidal surgery.This study is a retrospective analysis of 250 pituitary adenoma cases from January 2017 to December 2019 at our hospital. All patients underwent endoscopic endonasal transsphenoidal surgeries. Univariate and multivariate analyses were performed to investigate the risk factors associated with intra- and postoperative CSF rhinorrhea.Eighty (32.0%) and nine (3.6%) patients had intra- and postoperative CSF leakage, respectively. Tumor size was an independent risk factor for intraoperative CSF leakage (odds ratio [OR], 1.229; 95% confidence interval [CI], 1.133-1.334; P < .001); intraoperative CSF leakage was an independent risk factor for postoperative CSF leakage (OR, 7.707; 95% CI, 1.336-44.455; P = .022). Chronic respiratory disease (OR, 57.500; 95% CI, 8.031-411.682; P < .001) was also an independent risk factor for postoperative CSF leakage. Vascularized septal mucosal flap was a protective factor (OR, 0.107; 95% CI, 0.013-0.894; P = .039).Intraoperative CSF leakage is more likely to occur in large pituitary adenomas. In the presence of intraoperative CSF leakage, postoperative CSF rhinorrhea is very likely to occur. Patients with chronic respiratory disease are also more likely to develop postoperative CSF leakage. The sellar base reconstructed using vascularized nasal septal flaps can significantly decrease the risk. The Knosp grade, degree of tumor resection, and postoperative use of a lumbar subarachnoid drain did not have any effects on postoperative CSF rhinorrhea.Entities:
Mesh:
Year: 2021 PMID: 34889229 PMCID: PMC8663863 DOI: 10.1097/MD.0000000000027781
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Univariate analysis of impact of clinical characteristics associated with intraoperative CSF leak.
| Variable | No intraop leak (n = 170) | Intraop leak (n = 80) | |
| Gender | |||
| Female | 82 (48.2%) | 48 (60.0%) | .219 |
| Male | 88 (51.8%) | 32 (40.0%) | |
| Age (yr) | 44.15 ± 14.52 | 44.13 ± 15.85 | .992 |
| BMI (kg/m2) | |||
| <18.5 | 24 (14.1%) | 20 (25.0%) | .013 |
| 18.5–23.9 | 88 (51.8%) | 50 (62.5%) | |
| 24–27.9 | 44 (25.9%) | 6 (7.5%) | |
| ≥2 8.0 | 14 (8.2%) | 4 (5.0%) | |
| Hypertension | |||
| No | 144 (84.7%) | 60 (75.0%) | .191 |
| Yes | 26 (15.3%) | 20 (25.0%) | |
| Diabetes | |||
| No | 154 (90.6%) | 72 (90.0%) | 1.000 |
| Yes | 16 (9.4%) | 8 (10.0%) | |
| CRD | |||
| No | 162 (95.3%) | 72 (95.0%) | 1.000 |
| Yes | 8 (4.7%) | 4 (5.0%) | |
| Coronary heart disease | |||
| No | 154 (90.6%) | 76 (95.0%) | .621 |
| Yes | 16 (9.4%) | 4 (5.0%) | |
| Knosp Grade | |||
| 0 | 28 (16.5%) | 16 (20.0%) | .641 |
| 1–2 | 106 (62.4%) | 40 (50.0%) | |
| 3–4 | 36 (21.2%) | 24 (30.0%) | |
| Tumor size | 16.84 ± 6.16 | 26.20 ± 7.83 | <.001 |
| Consistency of the adenoma | .032 | ||
| Tenacious | 50 (29.4%) | 57 (71.3%) | |
| Soft | 120 (70.6%) | 23 (28.7%) | |
| Degree of tumor resection | |||
| GTR | 152 (89%) | 66 (83%) | .248 |
| STR | 14 (8.2%) | 12 (15%) | |
| PR | 4 (2.8%) | 2 (2%) | |
| Pathology | |||
| NF | 124 (72.9%) | 63 (78.8%) | .972 |
| ACTH | 16 (9.4%) | 4 (5.0%) | |
| GH | 28 (16.5%) | 12 (15%) | |
| PRL | 2 (1.2%) | 1 (1.2%) | |
Univariate analysis of impact of clinical characteristics associated with postoperative CSF leak.
| Variable | No postop leak (n = 241) | postop leak (n = 9) | |
| Gender | |||
| Female | 129 (53.5%) | 5 (55.6%) | 1.000 |
| Male | 112 (46.5%) | 4 (44.4%) | |
| Age (years) | 44.07 ± 14.67 | 45.25 ± 18.99 | .829 |
| BMI (kg/m2) | |||
| <18.5 | 40 (16.6%) | 2 (22.2%) | .462 |
| 18.5–23.9 | 141 (58.5%) | 2 (22.2%) | |
| 24–27.9 | 44 (18.3%) | 4 (44.5%) | |
| ≥28.0 | 16 (6.6%) | 1 (11.1%) | |
| Hypertension | |||
| No | 192 (79.7%) | 6 (66.7%) | .979 |
| Yes | 49 (20.3%) | 3 (33.3%) | |
| Diabetes | |||
| No | 212 (88.0%) | 7 (77.8%) | .565 |
| Yes | 29 (12.0%) | 2 (22.2%) | |
| CRD | |||
| No | 230 (95.4%) | 5 (55.6%) | <.001 |
| Yes | 11 (4.6%) | 4 (44.4%) | |
| Coronary heart disease | |||
| No | 216 (89.6%) | 7 (77.8%) | .497 |
| Yes | 25 (10.4%) | 2 (22.2%) | |
| Tumor size | 19.56 ± 7.82 | 23.75 ± 10.35 | .154 |
| Pathology | |||
| NF | 181 (75.1%) | 6 (66.7%) | |
| ACTH | 19 (7.9%) | 1 (11.1%) | |
| GH | 38 (15.8%) | 2 (22.2%) | |
| PRL | 3 (1.2%) | 0 (0.00%) | |
| Consistency of the adenoma | |||
| Tenacious | 119 (49.4%) | 5 (55.6%) | .383 |
| Soft | 122 (50.6%) | 4 (44.4%) | .451 |
| Knosp Grade | .864 | ||
| 0 | 42 | 1 | |
| 1–2 | 145 | 5 | |
| 3–4 | 54 | 3 | |
| Degree of tumor resection | .011 | ||
| GTR | 208 | 6 | |
| STR | 27 | 3 | |
| PTR | 6 | 0 | |
| Intraoperative CSF leak | .021 | ||
| No | 173 (71.8%) | 2 (22.2%) | |
| Yes | 68 (28.2%) | 7 (77.8%) | |
| Sella reconstruction methods | <.001 | ||
| synthetic dura+biological glue | 166 (68.9%) | 3 (33.3%) | |
| abdominal fat+ dura+free graft | 28 (11.6%) | 6 (66.7%) | |
| abdominal fat+ dure+VNSF | 47 (19.5%) | 0 (0%) | |
| lumbar subarachnoid drain | 0.286 | ||
| No | 226 (93.8%) | 7 (77.8%) | |
| Yes | 15 (6.2%) | 2 (22.2%) | |
Multivariate analysis of impact of clinical characteristics upon intraoperative CSF leak.
| Variable | OR | 95% CI for OR | |
| Tumor size | 1.229 | 1.133–1.334 | <.001 |
Multivariate analysis of impact of clinical characteristics upon postoperative CSF leak.
| Variable | OR | 95% CI for OR | |
| CRD | 57.500 | 8.031–411.682 | <.001 |
| Intraoperative CSF leak | 7.707 | 1.336–44.455 | .022 |
| VNSF+ abdominal fat graft | 0.107 | 0.013–0.894 | .039 |